Pharming Group

Pharming Group: Building a sustainable rare disease business, preparing for approval/launch of leniolisib for APDS. Revenues >$200M (TTM) from Ruconest (marketed) for the treatment of acute hereditary angioedema (HAE) attacks including breakthrough attacks. Leniolisib, a targeted PI3Kδ inhibitor initially being developed for PI3K delta syndrome (APDS), is on track to be the first approved disease-modifying treatment for APDS, a rare genetic immunodeficiency. Regulatory approvals expected from the US FDA in Q1 2023 and EU EMA in H1 2023 under priority review/ accelerated assessment, with commercial launch expected in the US H1 and EU H2 2023. Ruconest cash flow funds leniolisib and broader pipeline development. Dual listed on Nasdaq.
Based in...
Clinical Stage
Marketed, Registration Stage
Disease Space
Anti-inflammatory, Complement Mediated, Rare Disease
Profitable, Revenues
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
pi3k, Recombinant DNA, Small Molecule, Targeted Therapy
Vondellaan 47
Leiden, Zuid-Holland 2332AA

Company Participants at Solebury 1x1 Management Access Event 2023

  • Anurag Relan, Chief Medical Officer
  • Jeroen Wakkerman, CFO
  • Sijmen de Vries, CEO

Top 10 Holders of Pharming Group NV

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Acadian Asset Management LLC 3.07 19,982,959 0.00 Stakes 9/1/22
Victory Capital Management, Inc. (Investment Management) 0.01 47,698 0.00 Funds 10/31/22
KLP Kapitalforvaltning AS 0.02 117,591 0.00 Funds 11/30/22
Zürcher Kantonalbank (Investment Management) 0.02 112,073 0.00 Funds 11/30/22
Link Fund Solutions (Luxembourg) SA 0.02 100,000 0.00 Funds 2/28/22
Castlebay Investment Partners LLP 0.02 100,000 0.00 Funds 11/30/22
BlackRock Investment Management (UK) Ltd. 0.01 81,094 0.00 Funds 6/30/22
BlackRock Advisors (UK) Ltd. 0.01 65,201 0.00 Funds 7/31/22
Lingohr & Partner Asset Management GmbH 0.01 56,165 0.00 Funds 1/31/22
GAM Investment Management (Switzerland) AG 0.01 55,132 0.00 Funds 11/30/22

Top 10 Holders of Pharming Group NV ADR RegS

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Cowen Prime Advisors LLC 0.03 16,700 0.24 13F 9/30/22
Morgan Stanley Smith Barney LLC 0.01 6,750 0.10 13F 9/30/22
Geode Capital Management LLC 0.00 2,093 0.03 Funds 11/30/22
UBS Securities LLC 0.00 1,534 0.02 13F 9/30/22
Wells Fargo Clearing Services LLC 0.00 0 0.00 13F 9/30/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.